Crown Pharm Co., Ltd. announced a private placement of 136,365 common shares at a price of KRW 22,000 per share for gross proceeds of KRW 3,000,030,000 on May 23, 2018. The transaction included participation from existing investor GL Pharm Tech Corp. (KOSDAQ:A204840). The transaction was approved by the board of director of the investor. The company reported total assets of KRW 15,014,000,000, total liabilities of KRW 14,449,000,000, revenue of KRW 5,764,000,000, total capital KRW 1680,000,000, and net profit of KRW -1,341,000,000 for the year ended December 31, 2017.